Amerisourcebergen to expand global biopharma services platform with acquisition of pharmalex

Conshohocken, pa.--(business wire)--amerisourcebergen corporation (nyse: abc) today announced that it has signed a definitive agreement to acquire pharmalex holding gmbh, a leading provider of specialized services for the life sciences industry, from funds advised by auctus capital partners ag for €1.28 billion in cash, subject to certain customary adjustments. the transaction will advance amerisourcebergen's role as partner of choice for biopharmaceutical manufacturers by enhancing amerisource
COR Ratings Summary
COR Quant Ranking